How is Vascularization Targeted in Cancer Therapy?
Given its critical role in tumor growth, vascularization is a key target in cancer therapy. Anti-angiogenic drugs, such as bevacizumab, aim to inhibit VEGF and other angiogenic factors. These therapies can restrict the tumor's blood supply, thereby inhibiting its growth and reducing the likelihood of metastasis.
